Candela AlexTriVantage, Руководство оператора

Страница: 17 / 116

8501-00-1800, Revision 05 Confidential 1-3
Candela Corporation AlexTriVantage Laser System
The wavelength and pulse duration considerations outlined above indicate that the
AlexTriVantage Laser is appropriate for treatment of tattoos. The wavelength of the
AlexTriVantage Laser is about 755 nm, in the near-infrared region. It produces pulses
approximately 50 nanoseconds in duration. The pulse energies it produces allows delivery of
energies up to 625 mJ. Because the wavelength and pulse duration of the Candela
AlexTriVantage Laser are closely controlled, treatment of tattoos can be achieved with
minimal energy densities, reducing the possibility of adverse effects on adjacent normal skin
structures.
Indications for Use
The Candela AlexTriVantage, Q-Switched Alexandrite Laser, is indicated for the treatment of
tattoos or benign cutaneous pigmented lesions. The decision to treat with laser therapy
should be based upon appropriate diagnostic evaluation and consideration of all patient
factors.
Contraindications and Precautions
Do not treat recently tanned skin. Blisters and hyper / hypopigmentation may occur.
Allow tan to fade prior to treatment.
With infected "target" tattoo site or adjacent areas
With a personal history of skin cancer, such as melanoma.
Accutane: Wait 6 months after the completion of Accutane therapy
History of photosensitivity to infra red light..
Pregnancy: Refer to Candela Corporation policy # 0920-23-0814.
Seizure disorders :Do not treat patients with a history of light-triggered seizures.
Medications and Supplements : Daily anticoagulation therapy, iron supplements,
herbal supplements such as ginko, ginseng or garlic and fish oil supplements may
bruise more readily.
Photosensitizing Medications: Medications that induce photosensitivity or medications
within or above the 755nm wavelength range. Refer to Candela Corporation Drugs
That May Cause Photosensitivity. Stop the medication if possible for 3-5 days prior to
treatment.
Topical Medications and skin care products: Stop 72 hours pre and post
HSV 1 & 2: Do not treat if active lesion(s) are present within the intended treatment
area. Patients with a known history of frequent HSV 1&2 lesions should begin
prophylaxis prior to treatment as prescribed by their healthcare provider.
Poorly controlled Medical Conditions: These patients should be carefully evaluated by
their healthcare provider for medical clearance.
Active skin infection: Avoid treatment of open wounds and skin that is actively infected.
Cold sensitivity: Use caution when treating patients with Raynaud's phenomenon.
Keloid scarring: Perform test spots prior to treating larger areas.
Implanted medical devices: Pacemakers, cardioverters and other implantable devices
or fillers: consult healthcare provider.